Korro Bio, Inc. (KRRO)
12.18
+0.56
(+4.82%)
USD |
NASDAQ |
Sep 04, 13:57
Korro Bio Market Cap : 179.11M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 03, 2026 | 170.88M |
| September 02, 2026 | 176.03M |
| September 01, 2026 | 180.00M |
| August 31, 2026 | 183.67M |
| August 28, 2026 | 189.85M |
| August 27, 2026 | 195.00M |
| August 26, 2026 | 201.17M |
| August 25, 2026 | 201.91M |
| August 24, 2026 | 192.20M |
| August 21, 2026 | 193.82M |
| August 20, 2026 | 190.58M |
| August 19, 2026 | 205.14M |
| August 18, 2026 | 194.41M |
| August 17, 2026 | 193.23M |
| August 14, 2026 | 195.29M |
| August 13, 2026 | 195.44M |
| August 12, 2026 | 196.32M |
| August 11, 2026 | 195.88M |
| August 10, 2026 | 198.38M |
| August 07, 2026 | 194.85M |
| August 06, 2026 | 178.23M |
| August 05, 2026 | 169.11M |
| August 04, 2026 | 166.91M |
| August 03, 2026 | 154.90M |
| July 31, 2026 | 149.56M |
| Date | Value |
|---|---|
| July 30, 2026 | 150.72M |
| July 29, 2026 | 145.24M |
| July 28, 2026 | 151.44M |
| July 27, 2026 | 154.61M |
| July 24, 2026 | 153.46M |
| July 23, 2026 | 166.29M |
| July 22, 2026 | 168.74M |
| July 21, 2026 | 172.49M |
| July 20, 2026 | 165.86M |
| July 17, 2026 | 176.68M |
| July 16, 2026 | 177.11M |
| July 15, 2026 | 187.93M |
| July 14, 2026 | 191.39M |
| July 13, 2026 | 194.71M |
| July 10, 2026 | 209.99M |
| July 09, 2026 | 206.24M |
| July 08, 2026 | 212.30M |
| July 07, 2026 | 208.98M |
| July 06, 2026 | 202.78M |
| July 02, 2026 | 201.92M |
| July 01, 2026 | 196.87M |
| June 30, 2026 | 190.09M |
| June 29, 2026 | 190.31M |
| June 26, 2026 | 183.17M |
| June 25, 2026 | 175.52M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.05B |
| Oncolytics Biotech, Inc. | 104.70M |
| Sangamo Therapeutics, Inc. | 68.85M |
| Sarepta Therapeutics, Inc. | 2.347B |
| Anixa Biosciences, Inc. | 103.80M |
Market Cap Related Metrics
| PS Ratio | 61.38 |
| PEG Ratio | -0.4643 |
| Price to Book Value | 1.735 |
| Price | 12.18 |
| Earnings Yield | -82.18% |
| PEGY Ratio | -0.4643 |